Assessment of left ventricular dyssynchrony by speckle tracking echocardiography in children with duchenne muscular dystrophy

Autor: Olivier Cazorla, Charlene Bredy, Marie Vincenti, Catherine Barrea, Albano Melli, Alain Lacampagne, Pascal Amedro, Jérémy Fauconnier, Kathleen Lavastre, Pierre Meyer, Lucie Gamon, Audrey Agullo, Nicolas Lanot, Hamouda Abassi, François Rivier, Thibault Mura, Gregoire De La Villeon

Publikováno v: International Journal of Cardiovascular Imaging
International Journal of Cardiovascular Imaging, 2022, 38 (1), pp.79-89. ⟨10.1007/s10554-021-02369-y⟩
The international journal of cardiovascular imaging, Vol. 38, no.1, p. 79-89 (2022)

Purpose-Prognosis of Duchenne muscular dystrophy (DMD) is related to cardiac dysfunction. Two dimensional-speckle tracking echocardiography (2D-STE) has recently emerged as a non-invasive functional biomarker for early detection of DMD-related cardio

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b016da53b0c1e5c306e33e5af058bed
https://doi.org/10.1007/s10554-021-02369-y

Kcnk3 dysfunction exaggerates the development of pulmonary hypertension induced by left ventricular pressure overload

Autor: Rui Adão, Catherine Rucker-Martin, David Montani, P. Mendes-Ferreira, Mélanie Lambert, Valérie Domergue, Véronique Capuano, Rozenn Quarck, Maria-Rosa Ghigna, Frédéric Perros, Jean-Luc Vachiery, Hélène Leribeuz, Angèle Boet, Carmen Brás-Silva, Marc Humbert, Fabrice Antigny

Publikováno v: Cardiovascular Research
Cardiovascular Research, 2021, 117 (12), pp.2474-2488. ⟨10.1093/cvr/cvab016⟩

Aims Pulmonary hypertension (PH) is a common complication of left heart disease (LHD, Group 2 PH) leading to right ventricular (RV) failure and death. Several loss-of-function (LOF) mutations in KCNK3 were identified in pulmonary arterial hypertensio

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a241b92460cd4ef7709eedf91baf2bd8
https://lirias.kuleuven.be/handle/123456789/669103

Contribution of serotonin to cardiac remodeling associated with hypertensive diastolic ventricular dysfunction in rats

Autor: Rachel L Matz, Marie-France Champy, Laurent Monassier, Roland Lawson, Roy Combe, Katia Boutourlinsky, Walid Mokni, Julien Becker, Lahcen El Fertak, Halim Marzak, Ramaroson Andriantsitohaina, Olivia Wendling, Estelle Ayme-Dietrich, Stéphane Doly, Luc Maroteaux

Publikováno v: Journal of Hypertension
Journal of Hypertension, Lippincott, Williams & Wilkins, 2015, 33, pp.2310-2321
Journal of Hypertension, 2015, 33 (11), pp.2310-2321. ⟨10.1097/HJH.0000000000000695⟩
Journal of Hypertension, Lippincott, Williams & Wilkins, 2015, 33 (11), pp.2310-2321. ⟨10.1097/HJH.0000000000000695⟩
Journal of Hypertension, Lippincott, Williams & Wilkins, 2015, 33 (11), pp.2310-2321. 〈10.1097/HJH.0000000000000695〉

Objective: Left-ventricular hypertrophy and interstitial fibrosis are the main pathophysiological factors of heart failure with preserved ejection fraction. Blockade of the serotonin 5-HT 2B receptor (5-HT 2B R) has been shown to reduce cardiac hyper

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb41b81e6c0de9b8230e23ceedf8e748
https://hal.archives-ouvertes.fr/hal-01280414

Fibrinolysis for patients with intermediate-risk pulmonary embolism

Autor: Sebastian Schellong, Mustapha Sebbane, Thierry Danays, Samuel Z. Goldhaber, Guy Meyer, Irene M. Lang, Cecilia Becattini, Eric Vicaut, Francis Couturaud, Christian Kupatt, Bożena Sobkowicz, Adam Torbicki, Claudia Dellas, Franck Verschuren, Erich Bluhmki, Hélène Bouvaist, Abstr Act, Nicolas Meneveau, Branislav Stefanovic, Benjamin Brenner, Annette Geibel, Piotr Pruszczyk, Mareike Lankeit, Jan Beyer-Westendorf, Ana Franca, Nils Kucher, Klaus Empen, David Jiménez, Matija Kozak, Nazzareno Galiè, Holger Thiele, Antoniu Petris, Giancarlo Agnelli, Gerard Pacouret, Aldo Salvi, Stavros Konstantinides, Matteo Rugolotto, Massimiliano Palazzini

Publikováno v: Meyer, Guy; Vicaut, Eric; Danays, Thierry; Agnelli, Giancarlo; Becattini, Cecilia; Beyer-Westendorf, Jan; Bluhmki, Erich; Bouvaist, Helene; Brenner, Benjamin; Couturaud, Francis; Dellas, Claudia; Empen, Klaus; Franca, Ana; Galiè, Nazzareno; Geibel, Annette; Goldhaber, Samuel Z.; Jimenez, David; Kozak, Matija; Kupatt, Christian; Kucher, Nils; ... (2014). Fibrinolysis for patients with intermediate-risk pulmonary embolism. New England journal of medicine NEJM, 370(15), pp. 1402-1411. Massachusetts Medical Society MMS 10.1056/NEJMoa1302097
BASE-Bielefeld Academic Search Engine
New England Journal of Medicine
New England Journal of Medicine, Massachusetts Medical Society, 2014, 370 (15), pp.1402-11. 〈10.1056/NEJMoa1302097〉
New England Journal of Medicine, Massachusetts Medical Society, 2014, 370 (15), pp.1402-11. ⟨10.1056/NEJMoa1302097⟩

International audience; BACKGROUND: The role of fibrinolytic therapy in patients with intermediate-risk pulmonary embolism is controversial. METHODS: In a randomized, double-blind trial, we compared tenecteplase plus heparin with placebo plus heparin

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e8884407c666ea6ff838038ea707349a
https://pubmed.ncbi.nlm.nih.gov/25594091

Lung ultrasound: a diagnostic and prognostic tool at every step in the pathway of care for acute heart failure

Autor: Stefano Coiro, Tahar Chouihed, Nicolas Girerd, Faiez Zannad

Publikováno v: American Journal of Emergency Medicine
American Journal of Emergency Medicine, Elsevier, 2016, 34 (3), pp.656-657. ⟨10.1016/j.ajem.2015.12.030⟩

International audience

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::672a98df0170590656e4f13112d500e0
https://hal.univ-lorraine.fr/hal-01760250